- Home
- OPCH vs IRTC Comparison
OPCH vs IRTC Comparison
Compare OPCH & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPCH | IRTC |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | 1996 | 2016 |
Fundamental Metrics
Financial Performance| Metric | OPCH | IRTC |
|---|---|---|
| Price | $21.66 | $124.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | $36.57 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 2.9M | 557.1K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.25 | ★ 61.71 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $4,998,202,000.00 | $747,138,000.00 |
| Revenue This Year | $7.21 | $19.60 |
| Revenue Next Year | $8.55 | $15.94 |
| P/E Ratio | $73.66 | ★ N/A |
| Revenue Growth | 16.17 | ★ 26.24 |
| 52 Week Low | $18.01 | $100.85 |
| 52 Week High | $36.80 | $210.01 |
Technical Indicators
Market Signals| Indicator | OPCH | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 64.10 |
| Support Level | $19.61 | $111.37 |
| Resistance Level | $22.42 | $129.05 |
| Average True Range (ATR) | 0.70 | 5.82 |
| MACD | 0.08 | 1.99 |
| Stochastic Oscillator | 45.71 | 83.32 |
Price Performance
Historical ComparisonAbout OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
About IRTC iRhythm Technologies Inc.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.